Correlation Between Aquestive Therapeutics and Visionary Education

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Visionary Education at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Visionary Education into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Visionary Education Technology, you can compare the effects of market volatilities on Aquestive Therapeutics and Visionary Education and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Visionary Education. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Visionary Education.

Diversification Opportunities for Aquestive Therapeutics and Visionary Education

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Aquestive and Visionary is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Visionary Education Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Visionary Education and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Visionary Education. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Visionary Education has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Visionary Education go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and Visionary Education

Given the investment horizon of 90 days Aquestive Therapeutics is expected to generate 0.44 times more return on investment than Visionary Education. However, Aquestive Therapeutics is 2.25 times less risky than Visionary Education. It trades about 0.07 of its potential returns per unit of risk. Visionary Education Technology is currently generating about 0.02 per unit of risk. If you would invest  93.00  in Aquestive Therapeutics on October 10, 2024 and sell it today you would earn a total of  220.00  from holding Aquestive Therapeutics or generate 236.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Aquestive Therapeutics  vs.  Visionary Education Technology

 Performance 
       Timeline  
Aquestive Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aquestive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Visionary Education 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Visionary Education Technology are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Visionary Education showed solid returns over the last few months and may actually be approaching a breakup point.

Aquestive Therapeutics and Visionary Education Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aquestive Therapeutics and Visionary Education

The main advantage of trading using opposite Aquestive Therapeutics and Visionary Education positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Visionary Education can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Visionary Education will offset losses from the drop in Visionary Education's long position.
The idea behind Aquestive Therapeutics and Visionary Education Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Commodity Directory
Find actively traded commodities issued by global exchanges